Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from KMB

Is Kimberly-Clark Stock Underperforming the Dow?

Kimberly-Clark has underperformed the Dow over the past year, yet Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.

Barchart

What Are Wall Street Analysts' Target Price for Kimberly-Clark Stock?

Analysts continue to back Kimberly-Clark despite its recent stock lag, signaling confidence in its longer-term fundamentals.

Barchart

Here's What to Expect From Kimberly-Clark's Next Earnings Report

Kimberly-Clark will release its fourth-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Is Kimberly-Clark Stock Underperforming the Nasdaq?

While Kimberly-Clark has lagged behind the broader Nasdaq Composite over the past year, Wall Street analysts remain moderately optimistic about the stock’s prospects.

Barchart

Kimberly-Clark Stock: Is Wall Street Bullish or Bearish?

As Kimberly-Clark has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Kenvue's $48.7 Billion Sale Puts Consumer Staples ETFs Back In Vogue

Consumer staples ETFs, usually the quiet corner of the market, are suddenly in the spotlight. The $48.7 billion acquisition of Kenvue Inc. (NYSE:KVUE) by Kimberly-Clark Corp (NASDAQ:KMB) has stirred renewed interest in the sector, setting up a potential reshuffling of weightings across several big-name ETFs.

Benzinga

Options Corner: Kimberly-Clark's Implosion Offers An Unusual Informational Arbitrage Opportunity

Kimberly-Clark Corporation (NASDAQ:KMB) rattled its shareholders when it earlier announced its acquisition of consumer goods giant Kenvue Inc (NYSE:KVUE). Ordinarily, such an acquisition might make sense due to the implied expansion of the acquiring entity's product portfolio. However, Kenvue has been ground zero for a controversy involving the flagship over-the-counter…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Kenvue Stock Pops on News Kimberly-Clark Will Buy It for $48.7B. Is It Too Late to Buy KVUE Here?

Kenvue stock soars as Kimberly-Clark agrees to acquire the consumer health giant. Jim Cramer is positive on KVUE shares heading into 2026.

Barchart

Kimberly-Clark Stock Plunges Over 16%, Kenvue Surges 20% In Monday Pre-Market: What's Going On?

Shares of Kimberly-Clark Corporation (NASDAQ:KMB) plunged 16.15% during the pre-market trading session on Monday, after it announced the acquisition of Kenvue Inc. (NYSE:KVUE) on Monday. Meanwhile Kenvue stock surged 20.04%.

Benzinga

3 Safe and Steady Stocks for Any Market

Coca-Cola, Kimberly-Clark, and Healthpeak Properties offer stable dividends and steady growth, making them safe stocks for any market environment

MarketBeat

Kimberly-Clark Proves Resilient With Firm Sales In Shifting Market

Kimberly-Clark Corporation (NASDAQ:KMB) shares were trading higher in the premarket session on Thursday after the company reported third-quarter fiscal 2025 results.

Benzinga

The Saturday Spread: Use Distributional Bifurcation to Roadmap Your Options Trades

You wouldn’t dare fly in an airplane that wasn’t equipped with a working altimeter. It’s the same principle when it comes to data science and options trading.

Barchart

Is Kimberly-Clark Stock Underperforming the S&P 500?

Kimberly-Clark has lagged behind the broader S&P 500 Index over the past year, yet analysts on Wall Street remain moderately optimistic about its future prospects.

Barchart

Kimberly-Clark To Pay Around $40 Million Over Surgical Gown Designs

Kimberly-Clark Corporation (NASDAQ:KMB) will pay $40.4 million to settle a criminal charge related to selling adulterated MicroCool surgical gowns.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Kimberly-Clark Stock: Analyst Estimates & Ratings

Kimberly-Clark has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.

Benzinga

Kimberly-Clark Analysts Boost Their Forecasts After Upbeat Q2 Earnings

Kimberly-Clark Corporation (NASDAQ:KMB) posted better-than-expected earnings for the second quarter on Friday.

Benzinga

Kimberly-Clark Tops Q2 EPS Estimates, Stock Jumps Over 5%

Kimberly-Clark Corporation (NASDAQ:KMB) shares were trading higher in the premarket session on Friday as the company reported second-quarter adjusted earnings per share of $1.92, beating the analyst consensus estimate of $1.66.

Barchart

Kimberly-Clark's Quarterly Earnings Preview: What You Need to Know

Kimberly-Clark is set to report its second-quarter results later this month, and analysts are forecasting a double-digit drop in earnings.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Triple Your Kimberly-Clark Dividend with this Options Strategy

With markets becoming more volatile, investors might be more interested in generating income rather than capital gains. Using options we can more than triple the yield on our KMB shares by using a covered call strategy.

Barchart

How Is Kimberly-Clark's Stock Performance Compared to Other Consumer Defensive Stocks?

Although Kimberly-Clark has performed better than its industry peers over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Do Wall Street Analysts Like Kimberly-Clark Stock?

As Kimberly-Clark has lagged behind the broader market over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

MarketBeat

Dividend King Kimberly-Clark Is a Good Buy in 2025

High-yielding Dividend King Kimberly-Clark is well-positioned to sustain its capital return in 2025. The stock price is setting up to continue the uptrend.

Barchart

Kimberly-Clark’s Q1 2025 Earnings: What to Expect

Kimberly-Clark is scheduled to report its first-quarter results this month, with analysts anticipating a single-digit decline in earnings.

Barchart

Kimberly-Clark Stock: Is KMB Outperforming the Consumer Defensive Sector?

Although Kimberly-Clark has outperformed relative to the consumer defensive sector over the past year, Wall Street analysts maintain a cautious outlook on the stock’s prospects.

Barchart

Is Procter & Gamble Stock Underperforming the S&P 500?

Procter & Gamble has significantly underperformed the S&P 500 over the past year, yet analysts remain moderately bullish on the stock’s prospects.

1 2 3 4

People

Jim Cramer

503 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Healthpeak Properties

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.